Viewing Study NCT02059850

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:10 PM
Ignite Modification Date: 2026-03-27 @ 5:38 AM
Study NCT ID: NCT02059850
Status: WITHDRAWN
Last Update Posted: 2016-02-03
First Post: 2014-02-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Sponsor: Fred Hutchinson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Synovial Sarcoma View
None Myxoid/Round Cell Liposarcoma View
None Recurrent Adult Soft Tissue Sarcoma View
None Stage III Adult Soft Tissue Sarcoma View
None Stage IV Adult Soft Tissue Sarcoma View
Keywords: